| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.25 | 0.09 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.09 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |